Skip to main content
. Author manuscript; available in PMC: 2014 Aug 3.
Published in final edited form as: Breast Cancer Res Treat. 2013 Aug 3;140(3):587–601. doi: 10.1007/s10549-013-2644-5

Table 5. Interaction between genes related to growth factors.

Gene 1 Gene 2 wt 1/variant 2 OR (95% CI)1 variant 1/wt 2 OR (95% CI) variant 1/variant 2 OR (95% CI) p interaction
EGFR
(rs6944906) FGF1 (rs152528) 0.76 (0.59,0.99) 0.82 (0.71,0.95) 0.785 (0.70,1.05) 0.02
FGF2 (rs1960669) 0.83 (0.67,1.03) 0.86 (0.77,0.96) 1.05 (0.89,1.24) <0.01
(rs1558544) FGF2 (rs308395) 0.85 (0.65,1.10) 0.67 (0.50,0.89) 0.83 (0.30,2.31) <0.01
FGF2 (rs167428) 0.79 (0.63,0.98) 0.66 (0.47,0.91) 1.21 (0.62,2.38) 0.01
FGF2 (rs11837725) 0.84 (0.66,1.08) 0.62 (0.46, 0.83) 0.70 (0.19,2.49) 0.02
FGF2 (rs308441) 0.72 (0.56,0.93) 0.70 (0.52,0.94) 1.50 (0.61,3.71) <0.01
(rs6593205) FGF2 (rs1476214) 1.05 (0.83,1.33) 0.67 (0.54,0.83) 1.27 (0.88,1.83) 0.03
FGF2 (rs3789138) 0.93 (0.75,1.14) 0.68 (0.53,0.87) 1.11 (0.82,1.51) 0.03
FGF2 (rs3804158) 0.96 (0.78,1.18) 0.66 (0.51,0.86) 1.16 (0.87,1.57) 0.02
(rs17151957) EGF (rs4444903) 0.90 (0.75,1.08) 0.61 (0.43,0.86) 0.97 (0.69,1.36) 0.03
(rs6970262) FGF1 (rs4912876) 0.86 (0.68,1.09) 0.87 (0.69,1.10) 1.60 (1.00,2.54) 0.01
(rs723527) FGF2 (rs308441) 0.69 (0.48,0.99) 0.90 (0.76,1.07) 1.12 (0.72,1.75) 0.02
(rs3752651) FGF1 (rs34019) 0.86 (0.76,0.97) 0.96 (0.72,1.29) 2.60 (1.30,5.17) <0.01
ERBB2
(rs1810132) FGF1 (rs34016) 0.79 (0.55,1.13) 0.77 (0.64,0.93) 1.70 (0.87,3.34) 0.01
(rs1136201) EGFR (rs11770531) 0.71 (0.44,1.15) 1.04 (0.94,1.15) 0.25 (0.10,0.62) 0.04
FGFR2
(rs2981582) FGF2 (rs7700205) 1.33 (1.14,1.55) 0.80 (0.66,0.97) 1.85 (1.44,2.38) <0.01
FGF2 (rs17408757) 1.40 (1.21,1.62) 0.87 (0.71,1.07) 1.79 (1.36,2.34) 0.03
FGF2 (rs1960669) 1.36 (1.17,1.58) 0.87 (0.70,1.09) 1.97 (1.47,2.63) 0.01
FGF2 (rs6534365) 1.24 (1.03,1.50) 1.03 (0.77,1.38) 1.65 (1.12,2.43) 0.03
EGFR (rs17586365) 0.84 (0.44,1.61) 1.40 (1.21,1.63) 7.77 (2.24,26.93) 0.03
(rs6954351) 1.27 (0.61,2.62) 1.63 (1.40,1.89) 2.22 (0.85,5.78) 0.02
PDGFB
(rs9622978) FGF1 (250092) 0.95 (0.82,1.09) 1.03 (0.91,1.17) 0.59 (0.44,0.79) <0.01
FGF1 (rs4912868) 0.70 (0.57,0.86) 0.91 (0.78,1.07) 1.16 (0.82,1.62) <0.01
(rs2247128) FGF1 (rs4912868) 0.87 (0.66,1.13) 0.88 (0.73,1.07) 1.97 (1.07,3.63) 0.04
(rs6001512) FGF2 (rs308435) 1.01 (0.85,1.20) 1.02 (0.91,1.14) 1.47 (1.13,1.93) 0.03
NRG2
(rs265159) EGFR (rs2280653) 0.65 (0.45,0.92) 1.03 (0.82,1.30) 1.85 (0.71,4.81) <0.01
FGF1 (rs1609763) 1.02 (0.83,1.25) 1.08 (0.89,1.33) 1.72 (1.01,2.95) 0.04
(rs3863190) EGFR (rs9642391) 0.93 (0.78,1.11) 0.83 (0.51,1.35) 8.47 (1.91,37.54) 0.02
(rs2330951) 1.00 (0.81,1.25) 1.59 (1.03,2.46) 0.68 (0.22,2.10) 0.02
(rs2280653) 0.95 (0.71,1.27) 1.73 (1.14,2.62) 0.44 (0.05,4.29) 0.05
FGF1 (rs34019) 0.95 (0.84,1.09) 1.52 (1.05,2.21) 0.49 (0.21,1.14) <0.01
(rs265155) EGFR (rs12671550) 1.00 (0.87,1.16) 1.73 (1.20,2.50) 0.74 (0.36,1.51) 0.02
(rs2916092) EGFR (rs11770531) 0.23 (0.12,0.46) 0.97 (0.82,1.14) 0.98 (0.24,3.94) <0.01
(rs4912894) PDGFB (rs4821877) 1.32 (1.05,1.66) 1.07 (0.81,1.41) 0.92 (0.71,1.21) 0.05
(rs1800954) EGFR (rs172718945) 1.07 (0.97,1.18) 1.03 (0.48,2.23) 0.42 (0.24,0.73) 0.04
(rs17151957) 0.96 (0.80,1.15) 0.34 (0.18,0.66) 1.33 (0.18,9.57) 0.04
rs(1422187) EGFR (rs4947979) 1.60 (1.13,2.26) 1.17 (0.89,1.54) 0.67 (0.26,1.73) 0.01
(rs197197) FGF2 (rs11938826) 0.65 (0.44,0.96) 0.86 (0.72,1.01) 0.77 (0.52,1.16) 0.01
(rs11746363) EGFR (rs917880) 0.83 (0.70,0.98) 0.68 (0.45,1.02) 0.91 (0.53,1.57) 0.05
(rs13173983) EGFR (rs2280653) 0.79 (0.56,1.11) 0.72 (0.56.0.93) 0.50 (0.13,1.93) 0.02
FGF1 (rs152528) 1.08 (0.88,1.31) 0.97 (0.69,1.35) 0.55 (0.33,0.92) 0.05
(rs6580353) EGFR (rs11770531) 0.81 (0.46,1.42) 1.03 (0.86,1.22) 0.10 (0.01,0.76) 0.02
FGF2 (rs11938826) 0.72 (0.53,0.97) 0.90 (0.72,1.12) 1.61 (0.88,2.96) 0.03
(rs2436389) EGFR (rs11487218) 1.14 (0.88,1.48) 1.25 (1.10,1.42) 0.97 (0.77,1.23) 0.01
(rs10225877) 1.42 (0.96,2.11) 1.26 (1.13,1.41) 0.96 (0.6,1.41) <0.01
(rs6944906) 0.85 (0.72,0.97) 0.98 (0.84,1.15) 1.02 (0.89,1.17) 0.04
1

Odds Ratios (OR) and 95% Confidence Intervals (CI) adjusted for age, study, BMI during the referent year, parity and genetic admixture; table includes only statistically significant interactions